British Journal of Pharmacology · 2024 · 12 citations · 41 references
Life SciencesCardiologyImmunologyImmunopathologyInflammationInnate ImmunityImmunomodulatory DrugsInflammatory SignalingInnate Immune ActivationInnate Immune ModulationInnate Immune ResponseInnate Immune Signaling PathwaysCardiac Systolic FunctionFulminant MyocarditisImmune Homeostasis RegulationImmunomodulatory EffectsInnate Cytokine ResponsesInnate Immune EffectorsMyocarditis HistopathologyRna Sequencing (Rna-seq)
Background and Purpose Fulminant myocarditis (FM) is a myocardial inflammatory disease that can result from either viral diseases or autoimmune diseases. In this study, we have determined the treatment effects of immunomodulatory drugs on FM. Experimental Approach FM was induced in A/JGpt mice by intraperitoneal administration of coxsackievirus B3, after which immunoglobins were administered daily by intraperitoneal injection. On the seventh day, the cardiac structure and function were determined using echocardiography and cardiac catheterisation. Single‐cell RNA sequencing (scRNA‐seq) was performed to evaluate CD45 + cells in the heart. Key Results Immunoglobin, a typical immunomodulatory drug, dramatically reduced mortality and significantly improved cardiac function in mice with FM. ScRNA‐seq revealed that immunoglobin treatment effectively modulated cardiac immune homeostasis, particularly by attenuating overactivated innate immune responses. At the cellular level, immunoglobin predominantly targeted Plac8 + monocytes and S100a8 + neutrophils, suppressing their proinflammatory activities, and enhancing antigen processing and presentation capabilities, thereby amplifying the efficiency and potency of the immune response against the virus. Immunoglobin benefits are mediated by the modulation of multiple signalling pathways, including relevant receptors on immune cells, direction of inflammatory cell chemotaxis, antigen presentation and anti‐viral effects. Subsequently, Bst2-ILT7 ligand‐receptor‐mediated cellular interactions manipulated by immunoglobin were further confirmed in vivo. Conclusions and Implications Immunoglobin treatment significantly attenuated FM‐induced cardiac inflammation and improved cardiac function by inhibiting overactivated innate immune responses. LINKED ARTICLES This article is part of a themed issue Drugs and Drug Targets in Metabolic and Chronic Inflammatory Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.20/issuetoc
41
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon, Chet Birger, Helga Thorvaldsdóttir et al. · Cell Systems · 2015 · 14.5K citations · Full text
Inference and analysis of cell-cell communication using CellChat
Suoqin Jin, Christian F. Guerrero‐Juarez, Lihua Zhang et al. · Nature Communications · 2021 · 8.3K citations · Full text
Alida L.P. Caforio, Sabine Pankuweit, Eloisa Arbustini et al. · European Heart Journal · 2013 · 3.4K citations · Full text
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas
Xianwen Ren, Wen Wen, Xiaoying Fan et al. · Cell · 2021 · 935 citations · Full text